Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.37
+0.80 (3.92%)
Apr 25, 2025, 4:00 PM EDT - Market closed
KNSA Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for KNSA stock have an average target of 37.17, with a low estimate of 34 and a high estimate of 40. The average target predicts an increase of 73.98% from the current stock price of 21.37.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KNSA stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $34 | Buy | Reiterates | $34 | +59.14% | Apr 16, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +87.22% | Mar 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +87.22% | Nov 5, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +63.82% | Oct 30, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +87.22% | Sep 13, 2024 |
Financial Forecast
Revenue This Year
580.73M
from 423.24M
Increased by 37.21%
Revenue Next Year
589.63M
from 580.73M
Increased by 1.53%
EPS This Year
0.52
from -0.60
EPS Next Year
0.43
from 0.52
Decreased by -17.51%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 640.7M | 742.4M | 871.1M | ||
| Avg | 589.6M | 700.6M | 816.6M | ||
| Low | 555.0M | 646.6M | 759.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 51.4% | 25.9% | 24.3% | ||
| Avg | 39.3% | 18.8% | 16.6% | ||
| Low | 31.1% | 9.7% | 8.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.05 | 2.17 | 2.21 | ||
| Avg | 0.43 | 1.03 | 1.50 | ||
| Low | -0.23 | 0.34 | 0.82 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 402.6% | 115.1% | ||
| Avg | - | 137.0% | 46.3% | ||
| Low | - | -20.7% | -19.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.